Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
Palvella Therapeutics, Inc. (PVLA), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to treating rare genetic skin diseases. With a market capitalization of..
ClearPoint Neuro Inc. (NASDAQ: CLPT), a pioneering player in the healthcare sector, specifically in medical devices, is making waves with its innovative solutions for minimally invasive brain surgeries. This U.S.-based..
Viemed Healthcare, Inc. (VMD), a prominent player in the medical devices industry, is drawing significant interest from investors due to an attractive potential upside of nearly 97%. As a healthcare..
Canopy Growth Corporation (NYSE: CGC), a prominent player in the cannabis industry, offers investors a complex mix of opportunities and challenges. Headquartered in Smiths Falls, Canada, Canopy Growth has established..
Health Catalyst, Inc. (NASDAQ: HCAT) stands at a crucial juncture for investors seeking opportunities within the healthcare information services industry. With a market capitalization of $229.42 million, Health Catalyst operates..
iTeos Therapeutics, Inc. (NASDAQ: ITOS) is a compelling player in the biotechnology sector, specializing in the burgeoning field of immuno-oncology. With a market capitalization of approximately $448.68 million, iTeos is..
TruBridge, Inc. (TBRG) is an intriguing player in the health information services sector, a niche within the broader healthcare industry. Headquartered in Mobile, Alabama, TruBridge offers a comprehensive suite of..
CytomX Therapeutics, Inc. (NASDAQ: CTMX) is a notable player in the biotechnology sector, particularly within the oncology-focused arena. With a market capitalization of $341.37 million, the company is drawing attention..
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is making waves in the biotechnology sector, drawing attention with its formidable 176% revenue growth. Headquartered in South San Francisco, California, Rigel specializes in discovering,..
Candel Therapeutics, Inc. (NASDAQ: CADL), a burgeoning player in the biotechnology sector, is catching the attention of investors with its compelling potential upside of 305.50%. This clinical-stage biopharmaceutical company, headquartered..
Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading player in the healthcare sector, specializes in providing cutting-edge sequencing solutions designed to unravel genetically complex problems. With its robust portfolio..
Heron Therapeutics, Inc. (NASDAQ: HRTX), a biotechnology firm operating within the healthcare sector, presents a tantalizing opportunity for investors, bolstered by an impressive potential upside of 274.02%. Headquartered in Cary,..
Abeona Therapeutics Inc. (NASDAQ: ABEO), a clinical-stage biopharmaceutical company, stands out in the biotechnology industry with its innovative approach to treating life-threatening diseases through gene and cell therapies. The company,..
Outset Medical, Inc. (NASDAQ: OM), a trailblazer in the healthcare sector, is capturing investor attention with a promising potential upside of 90.18%, according to recent analyst ratings. As a company..
Chevron Corporation (NYSE: CVX), a stalwart in the energy sector, stands as one of the largest integrated oil & gas companies globally, with a commanding market capitalization of $317.92 billion...
Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) has emerged as a noteworthy player in the biotechnology sector, focusing on the development of innovative therapies for women’s cancers. Based in San Francisco, this..
Senseonics Holdings, Inc. (NYSE: SENS) has captured investor attention with its pioneering approach in the healthcare industry, specifically within the medical device segment. Specializing in continuous glucose monitoring (CGM) systems,..
Zhengye Biotechnology Holding L (ZYBT), a company rooted in the healthcare sector, operates primarily within the drug manufacturing industry, focusing on specialty and generic veterinary vaccines. Based in Jilin, China,..
UroGen Pharma Ltd. (NASDAQ: URGN) is capturing the attention of investors with its promising position in the biotechnology industry, particularly in the field of urothelial and specialty cancers. Based in..
